Patent: 6,461,605
✉ Email this page to a colleague
Summary for Patent: 6,461,605
Title: | Continuous low-dose cytokine infusion therapy |
Abstract: | A method is provided for treating conditions that are susceptible of treatment with a cytokine wherein the undesirable side effects normally associated with cytokine administration are diminished or eliminated. The method comprises continuously administering a low dose of a cytokine to an individual afflicted with a condition susceptible of treatment with the cytokine. In a preferred embodiment of the invention, chronic hepatitis C is treated by administering a low dose amount of interferon. |
Inventor(s): | Cutler; David L. (Morristown, NJ), Affrime; Melton B. (Flemington, NJ) |
Assignee: | Schering Corporation (Kenilworth, NJ) |
Application Number: | 10/104,287 |
Patent Claims: | see list of patent claims |
Details for Patent 6,461,605
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Hoffmann-la Roche Inc. | PEGASYS COPEGUS COMBINATION PACK | peginterferon alfa-2a and ribavirin | 125083 | 06/04/2004 | ⤷ Try a Trial | 2015-11-02 | |
Schering Corporation A Subsidiary Of Merck & Co., Inc. | PEGINTRON/ REBETOL COMBO PACK | peginterferon alfa-2b and ribavirin | 125196 | 06/13/2008 | ⤷ Try a Trial | 2015-11-02 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |